HEALTH Nightingale Health Oyj

1.902USD1.730 EUR · HEL-3.89%Mkt Cap: 114.78M USDP/E: —

Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, Europe, the Middle East, Africa, AMER, and the Asia-Pacific. The company's Health Check that detect…

Key Statistics

Company
Market Cap114.78M USD
Enterprise Value78.84M USD
Revenue (TTM)6.05M USD
Gross Profit3.13M USD
Net Income (TTM)-20.30M USD
Revenue/Share0.10 USD
Last Price1.902 USD
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees101
CountryFI
SectorHealthcare
IndustryHealth Information Services
ISINFI4000490875
Valuation
P/E (Trailing)—
P/E (Forward)-7.86
PEG—
EV/EBITDA-5.13
EV/Revenue13.04
P/S18.98
P/B2.14
EPS (TTM)-0.34 USD
EPS (Forward)-0.24 USD
52W Range
0.864052% of range2.852
52W High2.852 USD
52W Low0.8640 USD
Profitability
Gross Margin51.67%
Oper. Margin-341.79%
EBITDA Margin-254.23%
Profit Margin-335.73%
ROE-37.90%
ROA-31.82%
ROIC-117.36%
ROCE-36.43%
Growth
Revenue Growth29.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.96M USD
CapEx (TTM)2.43M USD
FCF Margin-109.76%
FCF Yield-5.78%
Net Debt-35.95M USD
Net Debt/EBITDA2.34
Net Debt/FCF—
Balance Sheet
Debt/Equity0.08
Current Ratio6.38
Quick Ratio5.97
Book Value/Sh0.89 USD
Cash/Share0.67 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.759 USD
Upside (mean)-7.5%
Target Range1.759 USD – 1.759 USD
# Analysts1
Ownership
Shares Out.40.65M
Float29.84M
Insiders33.57%
Institutions7.32%
Technical
SMA 501.411 (+34.8%)
SMA 2001.254 (+51.6%)
Beta0.11
S&P 52W Chg8.68%
Avg Vol (30d)121.16K
Avg Vol (10d)147.10K
Technical Indicators
RSI (14)57.8
MACD0.1542
MACD Signal0.1797
MACD Hist.-0.0255
BB Upper2.450 USD
BB Middle1.847 USD
BB Lower1.244 USD
BB Width65.29%
ATR (14)0.1431 USD
Vol Ratio (20d)0.86x

About Nightingale Health (HEL: HEALTH)

›

Nightingale Health (HEL: HEALTH) is listed on Nasdaq Helsinki, where its shares trade in EUR. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 101 employees.

The shares were at 1.730 EUR on 20 November 2026, down 29.0% over 52 weeks. Its 52-week range is 0.7860 EUR to 2.595 EUR: the price is 33.3% below the high and 120.1% above the low.

Its market capitalisation is 104.42M EUR.

Nightingale Health reports return on equity of -37.9%, an operating margin of -341.8% and revenue up 29.6% year over year.

It holds more cash than debt, a net cash position of 32.70M EUR. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 1.600 EUR is 7.5% below the current price.